Artificial Intelligence

Smashing its target, Hamilton Lane's new fund highlights intense investor appetite for assets powering AI, logistics, and the energy transition.

A new platform, Accelerated Clinical Trials (ACT), promises to slash drug development timelines by up to 20 months, but faces regulatory and ethical hurdles.

Nearmap's new AI-powered Roof Assessment promises to slash inspection costs and transform how large property portfolios are managed. Is this the future?

Digital consultancy Livefront hires top talent from Perficient and Credera to accelerate its AI-first strategy and integrate its recent merger with Zeal.

Rain Bird's new software integrations with Spectrum and Watertronics promise to revolutionize golf course management with data-driven precision and sustainability.

Forrester recognizes Kaltura for its AI, signaling a market shift toward hyper-personalized events, immersive avatars, and long-term content value.

Mwyngil Therapeutics starts clinical trials for a novel brain-penetrating drug, aiming to tackle neuroinflammation at its source in MS and Parkinson's.

The AlUla Contemporary Art Museum launches, blending ancient heritage with modern art and global partnerships to redefine Saudi Arabia's cultural landscape.

A new report reveals banks are past debating AI, focusing instead on responsible deployment for fraud and efficiency, signaling a pragmatic future.

Unveiled at NADA 2026, AccuTrade's new platform uses AI and risk-scoring to help dealers navigate a complex market and maximize profit on every single VIN.

AI robotics firm Realbotix sells its legacy crypto domain portfolio for $2.245M to an unexpected buyer: the new Bed Bath & Beyond, signaling a major Web3 push.

Izzi Software launches its Z/XDC debugger on VS Code, a strategic move to modernize legacy systems and solve the critical mainframe skills gap.

New Era Energy & Digital taps Charlie Nelson as COO with a huge incentive package to build a gigawatt-scale AI hub in Texas's energy-rich Permian Basin.

Brainomix launches its award-winning stroke AI platform with novel Net Water Uptake tech, promising to improve diagnoses, treatment decisions, and patient outcomes.

The analytics giant pays down debt and buys back stock, signaling financial health, but faces analyst skepticism over its long-term growth strategy.

India’s Polymatech signals a major U.S. market offensive, appointing a seasoned leader to drive growth and explore domestic manufacturing possibilities.

Hyperscale Data reaffirms its $100M Bitcoin plan to fund its AI data center, defying a 95% stock drop and major financial red flags. Is it genius or folly?

InsurTech firm Gain Life rebrands as Crosstie, signaling a strategic move to integrate AI automation across the entire P&C insurance lifecycle.

HearingLife's new Oticon Zeal uses a brain-inspired AI to deliver crystal-clear sound in an invisible design, changing how we treat hearing loss.

In a major talent coup, Evercore hires Jonathan Dale to lead its consumer group, signaling aggressive expansion in a recovering but volatile M&A market.